BOLpharma Production Facilities скачать в хорошем качестве

BOLpharma Production Facilities

The company’s end-to-end medical cannabis operation starts with its proprietary patented strains designed to produce specific cannabinoids. Plants are cultivated in controlled and automated greenhouses and monitored to ensure harvesting at the peak stage. Post-harvest handling is conducted on-site in B.O.L’s pharma-grade extraction and production facility where specific cannabinoids of above 98% purity are isolated. B.O.L produces API’s and custom made formulations in bulk or in any other required delivery method. With ownership of ten patented indications for CBD-based therapies, B.O.L is currently engaged in clinical trials in partnership with Israel’s HMO and major hospitals. The company has launched POC trials for increased appetite and CINV, ADHD, neuropathic pain, epilepsy, colitis, psoriasis, and Parkinson disease. B.O.L aims at Phase II trials for Fibromyalgia, Diabetic neuropathic pain, Crohn's disease, and Atopic Dermatitis. B.O.L is led by a seasoned team of medical experts, researchers, and business professionals bringing a wealth of experience and expertise in clinical research, precision agriculture, production and marketing of pharma and health products.